20 May 2013
Keywords: avila, names, imclone, daniel, lynch, chairman, usa-based
Article | 22 December 2008
USA-based Avila Therapeutics has named Daniel Lynch as its executive chairman. Mr Lynch was previously chief executive and chief financial
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2008
15 December 2008
17 May 2013
© 2013 thepharmaletter.com